Health Catalyst Reports First Quarter 2022 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Health Catalyst Reports First Quarter 2022 Results

Health Catalyst Inc. (HCAT) PT Lowered to $42 at Goldman Sachs

May 11, 2022 6:55 AM EDT

Goldman Sachs analyst Cindy Motz lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $42.00 (from $49.00) while maintaining a Buy rating.

The analyst commented, "Health Catalyst posted a good earnings report with revenue growth in the range of 24% year over year, and surprising the market with positive... More